Halozyme Therapeutics reported 12.51 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amarin 91.05 88.3 Jun/2023
Amgen 18.07 1.77 Jun/2026
Baxter International 151.95 65.95 Jun/2026
Cara Therapeutics 0.49 27.28 Mar/2026
Eli Lilly 32.9 7.37 Jun/2026
Halozyme Therapeutics 12.51 1.15 Jun/2026
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
MannKind 201.15 102.55 Mar/2026
Pfizer 11.48 2.16 Jun/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
United Therapeutics 19.15 1.27 Jun/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023